Follistatin 315 peptide
Follistatin 315 is another naturally occurring isoform of the follistatin protein, differing slightly in structure and distribution from Follistatin 344.
Follistatin 315 is found primarily in circulation and plays a role in regulating activin and myostatin signaling.
Like other follistatin variants, it has been studied in research related to muscle development and cellular regulation.
How Follistatin 315 peptide works
Follistatin 315 interacts with proteins in the TGF-β signaling pathway, including activins and myostatin. Through these interactions it may:
regulate cell growth and differentiation
influence muscle tissue development
modulate signaling pathways involved in tissue repair
Research suggests that different follistatin isoforms may have distinct biological distributions and regulatory roles.
Clinical trials and evidence
Research involving follistatin proteins has included laboratory studies, animal experiments, and limited clinical investigations, particularly in the context of muscle biology and regenerative medicine. Studies have explored:
the role of follistatin in regulating myostatin and activin signaling
experimental approaches to increasing muscle mass in animal models
gene therapy strategies for muscle-wasting disorders, such as muscular dystrophy
biological pathways involved in cell growth and tissue regeneration
Some experimental research has investigated the use of follistatin gene therapy in preclinical and early clinical settings, with the goal of modulating myostatin signaling to support muscle development.
However, most studies have focused on genetic delivery methods or naturally occurring follistatin proteins, and the specific use of Follistatin 315 as an isolated therapeutic agent has not undergone extensive clinical trials in humans.
As a result, current knowledge about its biological effects is derived largely from experimental and preclinical research rather than large controlled clinical studies.
Possible side effects of Follistatin 315:
Because Follistatin 315 interacts with activin and myostatin signaling pathways, its biological effects may influence processes related to cell growth and tissue regulation. Possible side effects may include:
headache
fatigue
injection site reactions
temporary changes in metabolic signaling pathways
As with other investigational proteins affecting TGF-β signaling pathways, the full safety profile in humans remains incompletely understood.
Additional research is required to clarify the potential long-term effects of follistatin-related therapies.